{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:19:29Z","timestamp":1791119969008,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:00:00Z","timestamp":1068768000000},"content-version":"vor","delay-in-days":2753,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1996,5]]},"abstract":"<jats:p>OBJECTIVE\u2003Circulating IGF\u2010I and IGF binding protein\u20103 (IGFBP\u20103) levels both increase in puberty where growth velocity is high. The amount of free IGF\u2010I is dependent on the IGF\u2010I level and on the concentrations of the specific IGFBPs. Furthermore, IGFBP\u20103 proteolysis regulates the bioavailability of IGF\u2010I. However, the concentration of free IGF\u2010I and possible IGFBP\u20103 proteolytic activity in puberty has not previously been studied.<\/jats:p><jats:p>SUBJECTS AND MEASUREMENTS\u2003We investigated serum levels of easily dissociable IGF\u2010I concentrations and ultrafiltrated free IGF\u2010I levels by specific assays in 60 healthy boys and in 5 boys with precocious puberty before and during GnRH agonist treatment. In addition, total serum IGF\u2010I, IGFBP\u20101 and IGFBP\u20103 levels as well as IGFBP\u20103 protease activity were determined.<\/jats:p><jats:p>RESULTS\u2003Free (dissociable and ultrafiltrated) IGF\u2010I concentrations were significantly higher in pubertal boys than in prepubertal children and correlated significantly with the molar ratio between IGF\u2010I and IGFBP\u20103 (<jats:italic>r<\/jats:italic>=0.69, <jats:italic>P<\/jats:italic>&lt;0.0001 and <jats:italic>r<\/jats:italic>=0.54, <jats:italic>P<\/jats:italic>=0.0008, respectively) and inversely with IGFBP\u20101 (<jats:italic>r<\/jats:italic>=\u22120.47, <jats:italic>P<\/jats:italic>&lt;0.0001 and <jats:italic>r<\/jats:italic>=\u22120.43, <jats:italic>P<\/jats:italic>=0.0003, respectively). Multiple regression analysis suggested that IGFBP\u20103 level, and not IGFBP\u20101, was the major determinant of the free IGF\u2010I serum level in normal boys. Free IGF\u2010I levels were elevated in boys with precocious puberty and decreased during GnRH treatment. IGFBP\u20103 proteolysis was constant throughout puberty (mean 20%).<\/jats:p><jats:p>CONCLUSIONS\u2003We conclude that easily dissociable and ultrafiltrated free IGF\u2010I serum levels are increased in boys with normal and precocious puberty and suggest that the increased free IGF\u2010I serum concentration in puberty primarily reflects changes in total concentrations of IGF\u2010I and IGFBPs secondary to increased GH secretion, but that it is not influenced by changes in IGFBP\u20103 proteolysis.<\/jats:p>","DOI":"10.1046\/j.1365-2265.1996.711531.x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T14:02:08Z","timestamp":1068818528000},"page":"515-523","source":"Crossref","is-referenced-by-count":60,"title":["Serum concentrations of free and total insulin\u2010like growth factor\u2010I, IGF binding proteins \u20101 and\u20103 and IGFBP\u20103 protease activity in boys with normal or precocious puberty"],"prefix":"10.1111","volume":"44","author":[{"given":"Anders","family":"Juul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Flyvbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels E.","family":"Skakkeb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,11,14]]},"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1996.711531.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1996.711531.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1996.711531.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:09:16Z","timestamp":1698365356000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1996.711531.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["10.1046\/j.1365-2265.1996.711531.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1996.711531.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}